NCT04678440 2025-07-02
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
Clinical Trials
10 trialsNCT02978196 2024-05-17
99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01383135 2024-01-12
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
Phase EARLY_PHASE1 Completed
NCT03858491 2022-09-26
OSIBOOST
Academisch Ziekenhuis Maastricht
Phase EARLY_PHASE1 Completed
NCT03158883 2021-10-20
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT02357836 2021-05-03
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT02628080 2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1 Completed
NCT02463994 2019-02-08
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT00221169 2009-02-05
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer
Toronto Sunnybrook Regional Cancer Centre
Phase EARLY_PHASE1 Completed